Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China
· Delayed Price · Currency is CNY 78.58
+0.62 (0.80%)
At close: Dec 5, 2025
SHA:688765 Revenue
Wuhan Healthgen Biotechnology had revenue of 9.53M CNY in the half year ending June 30, 2024, with 441.68% growth. This brings the company's revenue in the last twelve months to 28.39M, up 17.02% year-over-year. In the year 2024, Wuhan Healthgen Biotechnology had annual revenue of 25.22M with 3.92% growth.
Revenue (ttm)
28.39M
Revenue Growth
+17.02%
P/S Ratio
989.41
Revenue / Employee
179.70K
Employees
158
Market Cap
28.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.22M | 951.94K | 3.92% |
| Dec 31, 2023 | 24.26M | 10.86M | 81.08% |
| Dec 31, 2022 | 13.40M | -12.12M | -47.49% |
| Dec 31, 2021 | 25.52M | 3.95M | 18.33% |
| Dec 31, 2020 | 21.57M | 11.32M | 110.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kweichow Moutai | 178.58B |
| Contemporary Amperex Technology | 386.04B |
| Foxconn Industrial Internet | 776.69B |
| China Merchants Bank | 293.67B |
| Ping An Insurance (Group) Company of China | 996.47B |
| Zijin Mining Group Company | 327.44B |
| China Yangtze Power | 83.90B |
| Midea Group | 451.23B |